K. Higaki et al., FAS ANTIGEN EXPRESSION AND ITS RELATIONSHIP WITH APOPTOSIS IN HUMAN HEPATOCELLULAR-CARCINOMA AND NONCANCEROUS TISSUES, The American journal of pathology, 149(2), 1996, pp. 429-437
Apoptosis, a programmed cell death, can be observed in the tissues of
viral or autoimmune hepatitis and of hepatocellular carcinoma. Fas ant
igen (Fas) was proposed as a protein that triggers apoptosis. To eluci
date the relationship between Fas expression and its location in hepat
ocellular carcinoma cells, we histochemically examined Fas expression
by using 25 hepatocellular carcinoma tissues and their corresponding n
oncancerous tissues, which were surgically obtained from the same pati
ents. In addition, the relationship between Fas expression and apoptot
ic cea numbers was examined in the hematoxylin-and-eosin-stained speci
mens obtained from 23 of the 25 patients. Hepatocellular carcinoma tis
sues expressed Fas less frequently and more weakly than noncancerous t
issues. The majority of noncancerous specimens expressed Fas both on t
he surface and in the cytoplasm, whereas the majority of hepatocellula
r carcinoma expressed Fas only in the cytoplasm. Apoptotic cell counts
were significantly higher in Fas-expressing tissues than in Fas-negat
ive tissues. Among Fas-expressing tissues, the counts were higher in s
urface Fas-expressing tissues than in tissues that expressed only cyto
plasmic Fas (P < 0.01 to 0.05). Our findings indicate that the develop
ment of apoptosis in hepatocellular carcinoma tissues relates to not o
nly Fas expression but also its location.